Late Breaking Abstract - Improvement of risk in patients with severe chronic thromboembolic pulmonary hypertension after 24weeks treatment with subcutaneous treprostinil
P. Jansa (Prague, Czech Republic), R. Sadushi-Kolici (Vienna, Austria), G. Kopec (Krakow, Poland), N. Skoro-Sajer (Vienna, Austria), M. Halank (Dresden, Germany), I. Simkova (Bratislava, Slovakia), R. Steringer-Mascherbauer (Linz, Austria), B. Salobir (Ljubljana, Slovenia), W. Klepetko (Vienna, Austria), J. Lindner (Prague, Czech Republic), I. Lang (Vienna, Austria)
Source: International Congress 2022 – Diagnosis and epidemiology in pulmonary hypertension
Session: Diagnosis and epidemiology in pulmonary hypertension
Session type: Thematic Poster
Number: 1990
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Jansa (Prague, Czech Republic), R. Sadushi-Kolici (Vienna, Austria), G. Kopec (Krakow, Poland), N. Skoro-Sajer (Vienna, Austria), M. Halank (Dresden, Germany), I. Simkova (Bratislava, Slovakia), R. Steringer-Mascherbauer (Linz, Austria), B. Salobir (Ljubljana, Slovenia), W. Klepetko (Vienna, Austria), J. Lindner (Prague, Czech Republic), I. Lang (Vienna, Austria). Late Breaking Abstract - Improvement of risk in patients with severe chronic thromboembolic pulmonary hypertension after 24weeks treatment with subcutaneous treprostinil. 1990
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|